Early enteral nutrition still has advantages in patients undergoing pancreaticoduodenectomy by 이승환 & 이재길
© Journal of Thoracic Disease. All rights reserved.   J Thorac Dis 2016;8(10):E1340-E1342jtd.amegroups.com
The physiological benefits of enteral nutrition (EN) have 
been well documented, including its association with 
maintenance of the structural integrity of the gastrointestinal 
(GI) tract, reduced gut permeability, and increased mesenteric 
blood flow (1). EN has also been associated with reductions 
in infectious complications, mortality, length of hospital stay 
(LOS), and costs (2-5). Thus, enteral route is preferred in 
patients without a contraindication EN because it allows a 
faster recovery of patients.
The ESPEN guidelines recommend the provision 
of early EN (EEN) or early oral diet after GI surgery 
including pancreaticoduodenectomy (PD) (3). Previous 
studies reported the superiority of EEN to total parenteral 
nutrition (TPN) in terms of improving clinical outcomes 
in patients undergoing GI surgery (6). Furthermore, the 
beneficial effects of EEN in patients undergoing PD have 
been demonstrated by several studies.
A recent large multicenter randomized controlled trial 
showed that it was safe to allow patients undergoing upper 
GI surgery to eat normal food at will, immediately after a 
major surgery including PD (7). Furthermore, the enhanced 
recovery after surgery (ERAS) guidelines recommend 
the initiation of early oral diet after PD (8). Although 
institutions may differ from each other in terms of the time 
of starting EN or oral diet after PD, early diet at will after 
PD is a recent recommendation.
Despite recent recommendations, pancreatic surgeons 
tend to prefer delayed EN over EEN or early oral diet 
because of concerns about the occurrence of complications 
such as delayed gastric emptying (DGE), postoperative 
pancreatic fistula (POPF), postpancreatectomy hemorrhage 
(PPH), and infectious complications after EEN. However, 
the literature review by Buscemi et al. revealed that EEN 
is safe and tolerated in patients undergoing PD, but does 
not have clear advantages of reducing DGE, POPF, PPH, 
infectious complications, and LOS (9). 
In this issue of Annals of Surgery, Perinel et al. demonstrated 
contrasting results to those of previous studies that reported 
the benefits of EEN in patients undergoing PD (10). This was 
a prospective, multicenter, and randomized controlled trial 
involving 204 patients (age, >18 years) undergoing PD at 
nine French institutions. Eligible patients were randomly 
classified into two groups: those receiving EEN through 
the nasojejunal tube (NJEEN) and those receiving TPN 
postoperatively. NJEEN was defined as delivery of at least 
50% of nutritional needs through the nasojejunal tube by 
postoperative day (POD) 5, and the absence of parenteral 
nutrition for consecutive 72 h or more. NJEEN was infused 
at 2 mL/h on POD 1, with the rate increasing, as tolerated, 
by 25 mL/h every 24 h. TPN was also started on POD 1 
and delivered through a central venous catheter to achieve 
the target energy of 30 kcal·kg−1·day−1 with 1.5 amino 
acids·kg−1·day−1 with a carbohydrate-to-amino acids ratio 
of 3:2, which was continued until oral food intake reached 
60% of the nutritional requirements. The primary outcome 
was the incidence of overall postoperative complication 
(graded according to the Clavien-Dindo classification), and 
the secondary outcomes were the occurrence of infectious 
complications, POPF grade B/C, PPH grade B/C, DGE, the 
Comprehensive Complication Index, LOS, and 30-day and 
90-day mortality rates. In addition, the time to first flatus, 
time to starting oral food, and the impact on nutritional 
status (weight, body mass index, nutritional risk index, 
albumin, and prealbumin serum level) were evaluated. 
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This study has major implications and is a well-
organized randomized study that investigated the effect 
of postoperative nutrition in patients undergoing PD. 
However, it is necessary to reconsider a few points 
carefully. The common complications after PD include 
DGE (19–23%), POPF (9–22%, especially grade B/C 
19–22%), and PPH (1–17%, especially grade B/C 14%) 
(9,11-17). Among these complications, POPF was the most 
important risk factor for morbidity and mortality after PD. 
In general, the distribution of soft pancreatic texture was 
between 30% and 55% (11,18,19). However, only 5.4% 
of soft pancreas cases were observed in this study. The 
definition of soft pancreas in this study is different from 
that in previous publications. Nevertheless, the question 
of why the occurrence rate of POPF (27%) in this study 
was relatively higher than that in previous reports remains. 
In addition, the overall and individual complication rates 
reported in this study were relatively higher than those of 
previous studies. Furthermore, the overall complication, 
POPF, and the severity of POPF were significantly higher 
in the EEN group. This study concluded that EEN 
should not be recommended in patients undergoing PD. 
However, there is no strong evidence of an association 
between EEN and increased POPF. Therefore, it should 
be investigated whether EEN is significantly associated 
with a higher risk of POPF. Above all, we suggest that it 
is necessary to consider the risk factors that are associated 
with POPF. For example, other factors such as the 
anastomotic fashion, pancreatic duct stenting, or use of 
intraperitoneal drains should also be carefully considered 
as potential risk factors of POPF; however, these factors 
were not discussed in this study.
Another consideration is that patients receiving TPN 
were selected as a control group, and were initiated 
on TPN on POD 1. In the current guidelines, unless 
the patient is at high nutrition risk, early TPN is not 
recommended after GI surgery (20). Moreover, parenteral 
nutrition is not usually indicated in normally nourished 
patients if oral diet and EN is not contraindicated (20). 
Thus, the strategies for nutritional support after PD in this 
study are not in accordance with the current guidelines. 
Therefore, the results of this study should be interpreted 
with caution.
We conclude that EN or oral diet is safe and should 
be started as soon as possible after PD according to 
recommendations from the current guidelines. However, 
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